John Vergalla

2.3k total citations
39 papers, 1.9k citations indexed

About

John Vergalla is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, John Vergalla has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in John Vergalla's work include Neuropeptides and Animal Physiology (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Hepatitis C virus research (6 papers). John Vergalla is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Hepatitis C virus research (6 papers). John Vergalla collaborates with scholars based in United States, Netherlands and Canada. John Vergalla's co-authors include E. Anthony Jones, Nora V. Bergasa, Mark G. Swain, Richard B. Rothman, T. Jake Liang, Peter Schmid, David E. Kleiner, Yikyung Park, James E. Everhart and Jeanne G. Waggoner and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Hepatology.

In The Last Decade

John Vergalla

39 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Vergalla United States 24 928 774 355 292 257 39 1.9k
Motoyoshi Yano Japan 23 599 0.6× 592 0.8× 239 0.7× 150 0.5× 64 0.2× 67 1.7k
Tadasu Tsujii Japan 20 397 0.4× 472 0.6× 541 1.5× 225 0.8× 47 0.2× 73 1.6k
Kazuto Tajiri Japan 24 862 0.9× 829 1.1× 445 1.3× 345 1.2× 40 0.2× 93 2.2k
Robert H. Shikes United States 22 161 0.2× 204 0.3× 359 1.0× 137 0.5× 193 0.8× 37 1.5k
Carlos A. Luciano United States 15 153 0.2× 328 0.4× 174 0.5× 71 0.2× 96 0.4× 32 1.3k
Fiona J. Warner Australia 20 273 0.3× 400 0.5× 524 1.5× 138 0.5× 22 0.1× 37 2.1k
Åke Danielsson Sweden 24 1.3k 1.4× 1.6k 2.0× 349 1.0× 188 0.6× 21 0.1× 46 2.9k
Yuehua Huang China 28 400 0.4× 502 0.6× 660 1.9× 279 1.0× 47 0.2× 87 1.8k
Valérie Furlan France 17 212 0.2× 194 0.3× 280 0.8× 136 0.5× 186 0.7× 38 1.1k
Nozomu Shirasugi Japan 23 203 0.2× 430 0.6× 275 0.8× 224 0.8× 37 0.1× 78 3.0k

Countries citing papers authored by John Vergalla

Since Specialization
Citations

This map shows the geographic impact of John Vergalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Vergalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Vergalla more than expected).

Fields of papers citing papers by John Vergalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Vergalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Vergalla. The network helps show where John Vergalla may publish in the future.

Co-authorship network of co-authors of John Vergalla

This figure shows the co-authorship network connecting the top 25 collaborators of John Vergalla. A scholar is included among the top collaborators of John Vergalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Vergalla. John Vergalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Triyatni, Miriam, John Vergalla, Anthony R. Davis, et al.. (2002). Structural Features of Envelope Proteins on Hepatitis C Virus-like Particles as Determined by Anti-envelope Monoclonal Antibodies and CD81 Binding. Virology. 298(1). 124–132. 65 indexed citations
2.
3.
Lechmann, Martin, Kazumoto Murata, Jujin Satoi, et al.. (2001). Hepatitis C Virus-Like Particles Induce Virus–Specific Humoral and Cellular Immune Responses in Mice. Hepatology. 34(2). 417–423. 83 indexed citations
4.
Baumert, Thomas F., John Vergalla, Jujin Satoi, et al.. (1999). Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology. 117(6). 1397–1407. 104 indexed citations
5.
Yurdaydın, Cihan, Mark G. Swain, Eric D. Mininberg, et al.. (1998). Effect of inhibition of ornithine decarboxylase activity in a model of acute hepatocellular necrosis. European Journal of Gastroenterology & Hepatology. 10(6). 503–508. 1 indexed citations
6.
Baumert, Thomas F., Aldo Marrone, John Vergalla, & T. Jake Liang. (1998). Naturally Occurring Mutations Define a Novel Function of the Hepatitis B Virus Core Promoter in Core Protein Expression. Journal of Virology. 72(8). 6785–6795. 70 indexed citations
7.
Bergasa, Nora V., John Vergalla, Mark G. Swain, & E. Anthony Jones. (1996). Hepatic concentrations of proenkephalin‐derived opioids are increased in a rat model of cholestasis. Liver International. 16(5). 298–302. 49 indexed citations
8.
Bergasa, Nora V., David W. Alling, John Vergalla, & E. Anthony Jones. (1994). Cholestasis in the male rat is associated with naloxone-reversible antinociception. Journal of Hepatology. 20(1). 85–90. 91 indexed citations
9.
Tedeschi, Valeria, Geert Maertens, Adrian M. Di Bisceglie, et al.. (1994). Genotypic analysis of hepatitis C virus in American patients. Hepatology. 20(6). 1405–1411. 174 indexed citations
10.
Swain, Mark G., et al.. (1994). Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 266(2). G201–G205. 27 indexed citations
11.
Swain, Mark G., Vladimir K. Patchev, John Vergalla, George P. Chrousos, & E. Anthony Jones. (1993). Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.. Journal of Clinical Investigation. 91(5). 1903–1908. 72 indexed citations
12.
Swain, Mark G., John Vergalla, Nora V. Bergasa, & E. Anthony Jones. (1993). Sympathetic nerves, but not the adrenal gland, contribute to elevated plasma levels of met-enkephalin in rats with acute cholestatic hepatitis. Regulatory Peptides. 46(3). 535–542. 10 indexed citations
13.
Bergasa, Nora V., et al.. (1993). α‐Melanocyte‐Stimulating Hormone in Primary Biliary Cirrhosis. Annals of the New York Academy of Sciences. 680(1). 454–458. 2 indexed citations
14.
Bergasa, Nora V., et al.. (1993). Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. Life Sciences. 53(16). 1253–1257. 50 indexed citations
15.
Swain, Mark G., Melvyn P. Heyes, John Vergalla, & E. Anthony Jones. (1992). Methionine enkephalin accumulates in plasma but not in brain or cerebrospinal fluid of rats with acute toxic hepatitis. Neuroscience Letters. 141(2). 243–246. 3 indexed citations
16.
Bergasa, Nora V., et al.. (1992). 16, 16‐dimethyl prostaglandin E2 modulates aflatoxin B1‐induced injury of rat hepatocytes in primary culture: Possible role of cAMP. Journal of Gastroenterology and Hepatology. 7(6). 608–613. 3 indexed citations
17.
Bergasa, Nora V., Richard B. Rothman, John Vergalla, et al.. (1992). Central mu-opioid receptors are down-regulated in a rat model of cholestasis. Journal of Hepatology. 15(1-2). 220–224. 109 indexed citations
18.
Minuk, G. Y., John Vergalla, Reginald G. Hanson, et al.. (1986). Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.. Gut. 27(3). 324–328. 7 indexed citations
19.
Vergalla, John, Jones Ea, & Kew Mc. (1983). Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Determination of Pi phenotypes using iso-electric focusing.. PubMed. 64(24). 950–1. 9 indexed citations
20.
Karsh, Jacob, John Vergalla, & E. Anthony Jones. (1979). Alpha‐1‐antitrypsin phenotypes in rheumatoid arthritis and systemic lupus erythematosus. Arthritis & Rheumatism. 22(2). 111–113. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motoyoshi Yano Breakdown of academic impact, for papers by Tadasu Tsujii Breakdown of academic impact, for papers by Kazuto Tajiri Breakdown of academic impact, for papers by Robert H. Shikes Breakdown of academic impact, for papers by Carlos A. Luciano Breakdown of academic impact, for papers by Fiona J. Warner Breakdown of academic impact, for papers by Åke Danielsson Breakdown of academic impact, for papers by Yuehua Huang Breakdown of academic impact, for papers by Valérie Furlan Breakdown of academic impact, for papers by Nozomu Shirasugi
Rankless by CCL
2026